SARS Short description The severe acute respiratory syndrome (SARS) is an infectious disease caused by the SARS-associated coronavirus. It has similar symptoms as the flu. Detailed description SARS was observed for the first time in 2002 when an epidemic originating in China affected the whole world. More about “SARS” © Uniklinikum Heidelberg May 16 2022 Ernst Jung Prize for Medicine 2022 for renowned virologist Virologist Professor Ralf Bartenschlager has received the Ernst Jung Prize for Medicine 2022. The award, presented by the Jung Foundation for Science and Research, recognises scientists who conduct Mar 2022 mBio The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines Autoren McLean G et al. Mar 2022 Nat Metab Molecular consequences of SARS-CoV-2 liver tropism Autoren Wanner N et al. Mar 2022 SSM Qual Res Health Kopfkino: Phases of quarantine among asymptomatic SARS-COV-2 carriers in Germany Autoren Uellner F et al. Mar 2022 Viruses Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies Autoren Girl P et al. Mar 2022 J Clin Med Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy Autoren Töllner M et al. Mar 2022 United Eur Gastroent SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease Autoren Duengelhoef P et al. Mar 2022 Front Immunol Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany Autoren Dulovic A et al. Mar 2022 Int J Infect Dis SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach Autoren Layer E et al. Mar 2022 J Infect Dis NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 after natural infection is more potent than after vaccination Autoren Rieke GJ et al. Pagination < Zurück Current page 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Seite 1 Seite 2 Seite 3 Seite 4 Seite 5 Seite 6 Seite 7 Seite 8 Seite 9 Next page ››
Mar 2022 mBio The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines Autoren McLean G et al.
Mar 2022 SSM Qual Res Health Kopfkino: Phases of quarantine among asymptomatic SARS-COV-2 carriers in Germany Autoren Uellner F et al.
Mar 2022 Viruses Side-By-Side Evaluation of Three Commercial ELISAs for the Quantification of SARS-CoV-2 IgG Antibodies Autoren Girl P et al.
Mar 2022 J Clin Med Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy Autoren Töllner M et al.
Mar 2022 United Eur Gastroent SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease Autoren Duengelhoef P et al.
Mar 2022 Front Immunol Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany Autoren Dulovic A et al.
Mar 2022 Int J Infect Dis SARS-CoV-2 screening strategies for returning international travellers: Evaluation of a rapid antigen test approach Autoren Layer E et al.
Mar 2022 J Infect Dis NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 after natural infection is more potent than after vaccination Autoren Rieke GJ et al.
